It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Discover which credit card offers the best point redemption options. Get more value from your rewards and enjoy flexible choices.
27,034 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Bitcoin could test lower levels as bearish theses grow louder. This report outlines ticking risk factors, potential p...
U.S. oil refiners are set for a historic profit surge as supply disruptions and stronger demand push refining margins...
MicroStrategy’s once-buzzing retail following on Reddit is fading fast as the company sells crypto to fund dividends ...
The U.S. economy caught chill from tariff-driven price increases and Winter Storm Fern, with executives signaling a c...
Hyperliquid's native token continues a sharp weekly decline, reviving bearish bets as traders weigh on-chain signals ...
Anthropic confronts a Friday deadline in its fight with pentagon over how its AI can be used by the U.S. military. A ...
A top institutional SOL holder remains committed despite a near-$1 billion unrealized loss, shaping a long-term Solan...
The Strait of Hormuz has seen traffic grind to a near standstill as conflict escalates, sending ripples through oil p...
NVIDIA stock hovers in the mid-$170s, as traders debate whether the company can reach $500 per share by 2030 through ...
As labor markets stay tight, businesses are learning that unlocking discretionary effort hinges on culture and frontl...
Eli Lilly unveiled a direct-to-employer program for Zepbound, aiming to accelerate GLP-1 adoption and expand market s...